Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukemia-reactive donor T cells for relapsed or persistent mature B-cell neoplasms after allogeneic stem cell transplantation
NL-OMON37016Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2013
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in mature B-cell neoplasm (MBCN), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), acute lymphoblastic leukemia (ALL) and 1 more, sponsored by Leiden University Medical Center. Primary endpoints: Safety and Feasibility of product generation. Started Jun 2013; status: active, not recruiting.
02
Conditions
mature B-cell neoplasm (MBCN)chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)acute lymphoblastic leukemia (ALL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NL-OMON37016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37016.